Press Release Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Jul 24
Press Release Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares Jul 23
Press Release Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock Jul 21